INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 117 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $90,000 | -18.9% | 14,210 | +0.7% | 0.00% | 0.0% |
| Q2 2017 | $111,000 | +14.4% | 14,110 | -4.2% | 0.00% | 0.0% |
| Q1 2017 | $97,000 | -11.8% | 14,725 | -7.0% | 0.00% | 0.0% |
| Q4 2016 | $110,000 | -43.0% | 15,825 | -23.6% | 0.00% | -50.0% |
| Q3 2016 | $193,000 | +107.5% | 20,702 | +106.3% | 0.00% | +100.0% |
| Q2 2016 | $93,000 | -4.1% | 10,036 | -9.9% | 0.00% | 0.0% |
| Q1 2016 | $97,000 | +40.6% | 11,141 | +7.8% | 0.00% | 0.0% |
| Q4 2015 | $69,000 | +19.0% | 10,336 | +2.5% | 0.00% | 0.0% |
| Q3 2015 | $58,000 | -33.3% | 10,086 | -5.8% | 0.00% | 0.0% |
| Q2 2015 | $87,000 | -13.9% | 10,711 | -13.2% | 0.00% | 0.0% |
| Q1 2015 | $101,000 | -34.8% | 12,336 | -27.2% | 0.00% | -50.0% |
| Q4 2014 | $155,000 | -8.3% | 16,936 | -1.5% | 0.00% | 0.0% |
| Q3 2014 | $169,000 | -11.5% | 17,186 | -2.8% | 0.00% | 0.0% |
| Q2 2014 | $191,000 | – | 17,686 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 200,000 | $998,000 | 0.36% |
| Green Alpha Advisors, LLC | 72,647 | $363,000 | 0.24% |
| Skaana Management L.P. | 227,851 | $1,137,000 | 0.18% |
| SEVEN EIGHT CAPITAL, LP | 196,351 | $980,000 | 0.18% |
| Defender Capital, LLC. | 103,038 | $514,000 | 0.16% |
| Skaana Management L.P. | 206,300 | $1,029,000 | 0.16% |
| WASATCH ADVISORS LP | 4,926,125 | $24,581,000 | 0.10% |
| Parametrica Management Ltd | 16,183 | $81,000 | 0.08% |
| Cedar Brook Financial Partners, LLC | 54,500 | $272,000 | 0.07% |
| Hennion & Walsh Asset Management, Inc. | 274,703 | $1,371,000 | 0.07% |